Efter 52 ugers behandling havde 14 af 18 patienter (77, 8%) opnået vedligeholdelse eller forbedring i vægt/ alder- percentilen (over 3. percentil), 14 af 15 patienter (93, 3%) var over den 3. percentil for højde, og 12 af 15 patienter (80, 0%) var over den 3. percentil for hovedomkreds.
After 52 weeks of treatment 14 of 18 patients (77.8%) had maintained or improved weight-for-age percentiles (above the 3rd percentile), 14 of 15 patients (93.3%) were above the 3rd percentile for length and 12 of 15 patients (80.0%) were above the 3rd percentile for head circumference.